Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pharmacogenetics of Remifentanil in Patients With Hypertension Undergoing Cesarean Delivery Under General Anesthesia

This study has been completed.
General Teaching Hospital, Prague
Information provided by (Responsible Party):
Jan Blaha, MD, PhD., Charles University, Czech Republic Identifier:
First received: March 6, 2012
Last updated: November 14, 2014
Last verified: November 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2014
  Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):